1
/
of
1
Elabscience
SKU:PKSV030398
Recombinant SARS-CoV-2 Spike S1(A222V, D614G)(His Tag)
Recombinant SARS-CoV-2 Spike S1(A222V, D614G)(His Tag)
Regular price
$1,105.00 USD
Regular price
Sale price
$1,105.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 Spike S1(A222V, D614G)(His Tag), a cutting-edge product meticulously designed to cater to the ever-evolving demands of the scientific community. This exceptional offering showcases a recombinant form of the SARS-CoV-2 Spike S1 protein, incorporating the A222V and D614G mutations, further enhanced with a His Tag for enhanced detection and purification capabilities.
Crafted with utmost precision, this recombinant protein exhibits an unparalleled level of accuracy and reliability, making it an indispensable tool for researchers and scientists engaged in the study of SARS-CoV-2. The inclusion of the A222V and D614G mutations ensures that this product accurately represents the current viral strains, enabling comprehensive investigations into their functional characteristics and potential implications.
Moreover, the incorporation of the His Tag in this recombinant protein empowers researchers with an advanced means of detection and purification. This invaluable feature facilitates streamlined experimental workflows, allowing for efficient isolation and identification of the protein of interest. With enhanced sensitivity and specificity, this product enables researchers to delve deeper into the intricate mechanisms underlying SARS-CoV-2 infection and pathogenesis.
The Recombinant SARS-CoV-2 Spike S1(A222V, D614G)(His Tag) epitomizes excellence in scientific innovation, offering a reliable and versatile solution for a wide range of applications. Whether it be vaccine development, drug discovery, or diagnostic assay development, this product serves as an indispensable asset, empowering researchers to unravel the mysteries surrounding SARS-CoV-2 and contribute to the global fight against the ongoing pandemic.
In summary, the Recombinant SARS-CoV-2 Spike S1(A222V, D614G)(His Tag) stands as a testament to our unwavering commitment to scientific advancement. With its exceptional accuracy, enhanced detection capabilities, and versatility, this product is poised to revolutionize the field of SARS-CoV-2 research, enabling groundbreaking discoveries and paving the way for a brighter future.
Crafted with utmost precision, this recombinant protein exhibits an unparalleled level of accuracy and reliability, making it an indispensable tool for researchers and scientists engaged in the study of SARS-CoV-2. The inclusion of the A222V and D614G mutations ensures that this product accurately represents the current viral strains, enabling comprehensive investigations into their functional characteristics and potential implications.
Moreover, the incorporation of the His Tag in this recombinant protein empowers researchers with an advanced means of detection and purification. This invaluable feature facilitates streamlined experimental workflows, allowing for efficient isolation and identification of the protein of interest. With enhanced sensitivity and specificity, this product enables researchers to delve deeper into the intricate mechanisms underlying SARS-CoV-2 infection and pathogenesis.
The Recombinant SARS-CoV-2 Spike S1(A222V, D614G)(His Tag) epitomizes excellence in scientific innovation, offering a reliable and versatile solution for a wide range of applications. Whether it be vaccine development, drug discovery, or diagnostic assay development, this product serves as an indispensable asset, empowering researchers to unravel the mysteries surrounding SARS-CoV-2 and contribute to the global fight against the ongoing pandemic.
In summary, the Recombinant SARS-CoV-2 Spike S1(A222V, D614G)(His Tag) stands as a testament to our unwavering commitment to scientific advancement. With its exceptional accuracy, enhanced detection capabilities, and versatility, this product is poised to revolutionize the field of SARS-CoV-2 research, enabling groundbreaking discoveries and paving the way for a brighter future.
Share
